期刊文献+

败血症的肝功能特点及其对败血症的诊断价值 被引量:2

Liver Function Features of Septicaemia and Their Diagnostic Value on Septicaemia
在线阅读 下载PDF
导出
摘要 目的:探讨肝功能对败血症诊断的价值。方法:选择2010年2月-2012年4月住本院重症医学科的脓毒症患者,动态监测入选患者的血培养及肝功能,根据按败血症诊断标准回顾性将患者分为败血症组和非败血症组,分析各肝功能指标在两组中的变化特点及对败血症的诊断意义。结果:败血症组肝功能早期常见γ-谷氨酰转肽酶(γ-GGT)、碱性磷酸酶(ALP)、谷草转氨酶(AST)中1~3项升高。对比两组的第一次肝功能结果,败血症组的γ-GGT、ALP、AST显著高于非败血症组(P<0.01),其中γ-GGT升高对诊断败血症的诊断价值最高,以61.5μmmol/L为截断值,诊断败血症的灵敏度为87.5%,特异度为97.6%。21例γ-GGT升高,γ-GGT阳性时间早于败血症血病原菌培养阳性时间3~9d。败血症组高胆红素血症发生率为33.3%,显著高于非败血症组(9.5%)。结论:γ-GGT升高可作为败血症的早期筛查指标,特定的肝功能变化特点可能作为败血症临床诊断的依据之一。 Objective: To evaluate liver function tests as potential indicators of septicaemia. Method: Study was conducted between February 2010 and April 2012, included patients on admission ICU who suffered from sepsis, to dynamic monitor the blood cultures and liver function of the selected patients. According to the diagnostic criteria retrospectively the patients were divided into septicaemia group and non-septicaemia group. To analyze the indexes of liver function of the two groups, summarize the diagnostic role of liver function in septicaemia. Result: The serum levels of gamma- glutamyl, transpeptidase ( γ-GGT ), alkaline phosphatase ( ALP ), aspartate aminotransferase ( AST ) were in 1 to 3 increase universally at the early stage in septieaemia group. To compare the first liver function results of the two groups, serum levels of γ-GGT, ALP, AST of septicaemia group were significantly higher than those in non-septicaemia ( P〈0.O1 ) . Elevated γ-GGT levels in the diagnosis of septicaemia diagnostic value was the highest, with 61.5 μmmol/L cutoff value of the diagnosis of septicaemia, the sensitivity and specificity was 87.5% and 97.6% respectively. Twenty-one of the 24 patients with elevated γ-GGT levels had an increase in serum T -GGT 3 to 9 days before their initial positive blood culture. The incidence of hyperbilirubinemia in septicaemia group was 33.3%, which was significantly higher than that in non-septicaemia ( 9.5% ) . Conclusion: Elevated γ- GGT level can be served as a early indicator of screening septicemia.Specific features of liver function may be a clinical diagnosis of septicaemia.
出处 《中国医学创新》 CAS 2013年第15期139-141,共3页 Medical Innovation of China
关键词 肝功能 高胆红素血症 败血症 脓毒症 Liver functions Hyperbilirubinemia Septicaemia Sepsis
  • 相关文献

参考文献5

  • 1Dellinger R P, Carlet J M, Masur H, et al. Surviving sepsis campaignguidelines for management of severe sepsis and septic shock[J].CritCare Med, 2004, 32 ( 3 ) :858-873.
  • 2陈灏珠,林果为.实用内科学[M].第13版.北京:人民卫生出版社,2009:2005-2011.
  • 3Kanai S,Honda T,Uehara T, et al. Liver function tests in patients withbacteremia[J].J Clin Lab Anal, 2008,22 ( 1 ) :66-69.
  • 4Richard K G, Mark E M,John L G. Cholestasis of sepsis[J].BestPractice & Research Clinical Gastroenterology, 2003, 17 ( 3 ):357-367.
  • 5许建明.急性药物性肝损伤诊治建议(草案)[J].中华消化杂志,2007,27(11):765-767. 被引量:351

二级参考文献16

  • 1Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis, 2002, 22: 145-155.
  • 2Amacher DE. Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul Toxicol Pharmacol, 1998, 27:119-130.
  • 3Andrade RJ, Lucena MI, Pachkoria K, et al. Chronic liver damage after an episode of idiosyncratic drug induced liver injury (DILI). J Hepatol, 2006, 44(suppl 2):S247.
  • 4Nathwani RA, Kaplowitz N. Drug hepatotoxicity. Clin Liver Dis, 2006, 10:207-217.
  • 5Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol, 1990, 11 : 272-276
  • 6Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf, 2007, 30:277-294.
  • 7Temple R. Hy's law: predicting serious hepatotoxicity. Pharmaco epidemiol Drug Saf, 2006, 15 : 241-243.
  • 8Poison J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology, 2005, 41 : 1179-1197.
  • 9Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med, 2006, 354:731-739.
  • 10Aithal GP, Rawlins MD, Day CP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol, 2000, 33:949-952.

共引文献797

同被引文献17

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部